Washington, D.C. (July 8, 2016) – The Biotechnology Innovation Organization (BIO) congratulates the U.S. Senate for approving the bipartisan Roberts-Stabenow GMO labeling and disclosure solution and now urges passage by the U.S. House of Representatives.
“BIO applauds last night’s Senate vote to pass the GMO disclosure legislation,” said Jim Greenwood, BIO’s President and CEO. “We thank Senators Roberts and Stabenow for their leadership and congratulate them, along with other Senate and House leaders, on advancing this much-needed legislative remedy to the GMO disclosure issue.”
“But the work isn’t finished,” added Greenwood. “BIO urges the House of Representatives to take up and pass this bill without further modification next week so that it can be sent to President Obama for his signature before the Congress adjourns for the summer recess.”
About BIO
BIO is the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe. BIO members range from biotech start-ups to some of the world’s largest biopharmaceutical companies – all united by the same goal: to develop medical and scientific breakthroughs that prevent and fight disease, restore health, and improve patients’ lives. BIO also organizes the BIO International Convention and a series of annual conferences that drive partnerships, investment, and progress within the sector. Learn more at bio.org.